A carregar...
Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study
PURPOSE: This study was designed to assess the clinical efficacy and safety of anlotinib with immunotherapy in advanced non-small cell lung cancer as third-line therapy. PATIENTS AND METHODS: A total of 101 patients with advanced non-small cell lung cancer who were treated with anlotinib combined wi...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7585515/ https://ncbi.nlm.nih.gov/pubmed/33116888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S280096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|